While GLP-1 RAs are not typically prescribed solely as injectable treatments for depression, their impact on overall well-being, including mood, is a significant area of ongoing research
Vergani L, Lanza C, Rivaro P, Abelmoschi ML, Genti S, Veneselli E, Minniti G, Grasselli E, Canesi L, Voci A: Metals, metallothioneins and oxidative stress in blood of autistic children
The experimental nature of microdosing carries unknown risks that could include reduced efficacy, unexpected side effects, or long-term complications
However, only the injectable form has been available because peptide drugs are usually not suitable for administration via the oral route, as they present low oral bioavailability, are inactivated when they reach the gastrointestinal tract, and have low rates of diffusion into the cell [31, 32]